interleukin-20,monoclonal antibody 7e, and uses thereof

Ming-Shi Chang

interleukin-20,monoclonal antibody 7e, and uses thereof

Ming-Shi Chang (Inventor)

Department of Biochemistry and Molecular Biology

Research output: Patent

Abstract

Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

Translated title of the contribution	Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
Original language	English
Patent number	7435800
Publication status	Published - 2006 Jun 29

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{3f0e106d7856435ba09c041528828495,

title = "interleukin-20,monoclonal antibody 7e, and uses thereof",

abstract = "Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.",

author = "Ming-Shi Chang",

year = "2006",

month = jun,

day = "29",

language = "English",

type = "Patent",

note = "7435800",

}

TY - PAT

T1 - interleukin-20,monoclonal antibody 7e, and uses thereof

AU - Chang, Ming-Shi

PY - 2006/6/29

Y1 - 2006/6/29

N2 - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

AB - Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.

M3 - Patent

M1 - 7435800

ER -

interleukin-20,monoclonal antibody 7e, and uses thereof

Abstract

UN SDGs

Fingerprint

Cite this